VLKIM
CAH icon

Van Lanschot Kempen Investment Management’s Cardinal Health CAH Stock Holding History

Van Lanschot Kempen Investment Management’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-254,605
Closed -$30.1M – 233
2024
Q4 		$30.1M Buy
254,605
+2,681
+1% +$313K 0.3% 78
2024
Q3 		$27.8M Buy
251,924
+4,756
+2% +$497K 0.28% 92
2024
Q2 		$24.3M Buy
247,168
+3,250
+1% +$331K 0.27% 88
2024
Q1 		$27.3M Sell
243,918
-103,731
-30% -$11.2M 0.34% 79
2023
Q4 		$35M Sell
347,649
-29,384
-8% -$2.92M 0.49% 64
2023
Q3 		$32.7M Buy
377,033
+65,898
+21% +$5.96M 0.61% 57
2023
Q2 		$29.4M Sell
311,135
-7,182
-2% -$607K 0.53% 68
2023
Q1 		$24M Buy
318,317
+1,577
+0.5% +$119K 0.46% 78
2022
Q4 		$24.3M Sell
316,740
-14,683
-4% -$1.12M 0.71% 56
2022
Q3 		$22.1M Sell
331,423
-73,276
-18% -$4.64M 0.89% 36
2022
Q2 		$21.2M Sell
404,699
-39,795
-9% -$2.26M 0.76% 49
2022
Q1 		$25.2M Sell
444,494
-74,516
-14% -$3.99M 0.77% 51
2021
Q4 		$26.7M Buy
519,010
+54,182
+12% +$2.66M 0.83% 44
2021
Q3 		$23M Buy
464,828
+633
+0.1% +$34.3K 0.83% 44
2021
Q2 		$26.5M Buy
464,195
+52,698
+13% +$3.08M 0.95% 34
2021
Q1 		$25M Buy
411,497
+6,770
+2% +$374K 1.15% 30
2020
Q4 		$21.7M Buy
404,727
+50,027
+14% +$2.6M 1.26% 24
2020
Q3 		$16.7M Buy
354,700
+28,780
+9% +$1.48M 1.26% 31
2020
Q2 		$17M Sell
325,920
-40,740
-11% -$2.1M 1.24% 34
2020
Q1 		$17.6M Sell
366,660
-57,730
-14% -$3M 1.46% 12
2019
Q4 		$21.5M Sell
424,390
-52,600
-11% -$2.72M 1.34% 29
2019
Q3 		$22.5M Buy
476,990
+35,750
+8% +$1.63M 1.79% 8
2019
Q2 		$20.8M Buy
441,240
+61,270
+16% +$2.83M 1.81% 7
2019
Q1 		$18.3M Buy
379,970
+13,435
+4% +$673K 1.66% 12
2018
Q4 		$16.3M Sell
366,535
-40,055
-10% -$2.09M 1.82% 20
2018
Q3 		$22M Sell
406,590
-14,710
-3% -$753K 1.76% 15
2018
Q2 		$20.6M Buy
+421,300
New +$23.9M 1.54% 25

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Van Lanschot Kempen Investment Management's CAH Position: Q1 2025 in Review

Van Lanschot Kempen Investment Management sold out of Cardinal Health (CAH) in Q1 2025, closing a stake of 254,605 shares — an estimated $30.1M sold.

Van Lanschot Kempen Investment Management first reported a position in CAH in Q2 2018 and held it in 27 quarters. The position peaked at $35M in Q4 2023. 1,150 funds tracked by Wall St. Rank hold CAH as of Q1 2025.

  • Van Lanschot Kempen Investment Management reported no remaining Cardinal Health position as of Q1 2025 after selling out during the quarter.
  • Van Lanschot Kempen Investment Management sold 254,605 Cardinal Health shares in Q1 2025, an estimated $30.1M.
  • Van Lanschot Kempen Investment Management first reported a position in Cardinal Health in Q2 2018 and held it in 27 quarters.
  • Van Lanschot Kempen Investment Management's Cardinal Health position peaked at $35M in Q4 2023.
  • 1,150 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2025.

Based on Van Lanschot Kempen Investment Management's 13F filing for Q1 2025, filed 14 May 2025.